askbio

Private

—Biotechhttps://askbio.com

Last Round

M&A

Oct 26, 2020

Last Round Size

$2B

Est. Valuation

$4B

Total Funding Raised

$2.24B

Company Overview

AskBio is a biopharmaceutical company specializing in the development and manufacturing of Adeno-Associated Virus (AAV) gene therapy therapeutics for rare and generally untreatable genetic disorders.

Sector

Biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

askbio Comparables

Compare askbio with similar companies based on industry and business-model similarity.

No public comparables are available for askbio. Request access to learn about comparables coverage.

Request access

askbio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Oct 26, 2020
Grant	Sep 2, 2020
Series A	Apr 11, 2019
Grant	Jul 22, 2004

View all Funding Rounds

askbio Filings

Explore SEC and related filing metadata, where available.

askbio filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

Headquarters—

Year Founded2001

Last FundingOct 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?